Literature DB >> 15053191

Molecular biology of myocardial recovery.

Jianyi Zhang1, Jagat Narula.   

Abstract

The use of LVADs that leads to a dramatic mechanical and hemodynamic unloading of the failing left ventricle offers a unique opportunity to investigate the mechanisms of remodeling and reverse remodeling. Although it is being increasingly realized that the LVAD unloading results in regression of hypertrophy and improvement of myocyte function and LV geometry, the cellular and molecular mechanisms responsible for these beneficial effects remain undefined. The favorable alterations in geometry that occur in parallel fashion at the organ, cellular, and molecular levels are most likely caused by the reduced LV wall stress/stretch as a consequence of the mechanical support provided by LVAD. If it is confirmed that LVAD unloading can contribute significantly to reverse remodeling, the role of LVADs may graduate from bridge-to-transplantation or destination therapy to bridge-to-recovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053191     DOI: 10.1016/S0039-6109(03)00222-6

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Mechanical circulatory support in the UK.

Authors:  Stephen Westaby; Philip Poole-Wilson
Journal:  BMJ       Date:  2007-01-27

2.  Continuous flow left ventricular pump support and its effect on regional left ventricular wall stress: finite element analysis study.

Authors:  Choon-Sik Jhun; Kay Sun; Joshua P Cysyk
Journal:  Med Biol Eng Comput       Date:  2014-10-05       Impact factor: 2.602

Review 3.  Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.

Authors:  Jianglong Hou; Y James Kang
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

4.  Computational analysis of the hemodynamic characteristics under interaction influence of β-blocker and LVAD.

Authors:  Kaiyun Gu; Zhe Zhang; Yu Chang; Bin Gao; Feng Wan
Journal:  Biomed Eng Online       Date:  2018-12-03       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.